Acorda Therapeutics, Inc. logo

Acorda Therapeutics, Inc.

206 employees · est. 1995 · United States

VS
GliaPharm SA logo

GliaPharm SA

Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases

11 employees · est. 2016 · Geneva, Switzerland

Acorda Therapeutics, Inc. is the older company (1995 vs 2016); Acorda Therapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

Acorda Therapeutics, Inc. GliaPharm SA
Founded
1995 older 2016
Headquarters
United States Geneva, Switzerland
Employees
206 larger 11
Industry
Health Care, Manufacturing Biotechnology, Health Care
Funding Stage
Post Ipo Equity Grant
Total Funding
Not tracked yet $6.30M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Neurological Disorders, Therapies, Commercial-stage, Multiple Sclerosis, Spinal Cord Injury, Nervous System Disorders, FDA-approved, Biopharmaceutical, Clinical Development, Pharmaceutical Company, Zanaflex, Ampyra, New York Neurological Disorders, Psychiatric Disorders, Glial Cells, Brain Metabolism, Neuroprotection, Cognitive Functions, Switzerland, Therapeutic Approach, Biopharmaceuticals
Website
acorda.com gliapharm.com
Acorda Therapeutics, Inc. logo

About Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is a publicly traded (NASDAQ: ACOR) biotechnology company, founded in 1995. The company's mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. Initially established as a network of scientists, physic...

GliaPharm SA logo

About GliaPharm SA

GliaPharm is a Swiss-based biotechnology company founded in 2016, specializing in the development of treatments for neurological and psychiatric disorders. The company's slogan "Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases" encapsulates its innovative approach. GliaPhar...

We will tell you when either one moves

BounceWatch watches Acorda Therapeutics, Inc. and GliaPharm SA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Acorda Therapeutics, I... and GliaPharm SA — by email.

Frequently Asked Questions

Acorda Therapeutics, Inc.. GliaPharm SA — Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Acorda Therapeutics, Inc. has raised undisclosed funding while GliaPharm SA has raised $6.30M.
Acorda Therapeutics, Inc. and GliaPharm SA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Acorda Therapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Acorda Therapeutics, Inc. on 12 Sep 2024, and GliaPharm SA on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes